Salud financiera de hoja de balance de Qingdao Vland Biotech
Salud financiera controles de criterios 5/6
Qingdao Vland Biotech has a total shareholder equity of CN¥1.9B and total debt of CN¥750.7M, which brings its debt-to-equity ratio to 40.4%. Its total assets and total liabilities are CN¥3.0B and CN¥1.2B respectively. Qingdao Vland Biotech's EBIT is CN¥116.7M making its interest coverage ratio 7.7. It has cash and short-term investments of CN¥500.6M.
Información clave
40.4%
Ratio deuda-patrimonio
CN¥750.67m
Deuda
| Ratio de cobertura de intereses | 7.7x |
| Efectivo | CN¥500.55m |
| Patrimonio | CN¥1.86b |
| Total pasivo | CN¥1.17b |
| Activos totales | CN¥3.03b |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Some Qingdao Vland Biotech INC. (SHSE:603739) Shareholders Look For Exit As Shares Take 27% Pounding
Sep 05
Qingdao Vland Biotech INC.'s (SHSE:603739) Popularity With Investors Under Threat As Stock Sinks 26%
Jun 07Investors Shouldn't Be Too Comfortable With Qingdao Vland Biotech's (SHSE:603739) Earnings
May 06Qingdao Vland Biotech INC. (SHSE:603739) Might Not Be As Mispriced As It Looks
Apr 16Análisis de la situación financiera
Pasivos a corto plazo: 603739's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥1.0B).
Pasivo a largo plazo: 603739's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥155.7M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 603739's net debt to equity ratio (13.5%) is considered satisfactory.
Reducción de la deuda: 603739's debt to equity ratio has increased from 3% to 40.4% over the past 5 years.
Cobertura de la deuda: 603739's debt is well covered by operating cash flow (22.9%).
Cobertura de intereses: 603739's interest payments on its debt are well covered by EBIT (7.7x coverage).